How the SARS vaccine effort can learn from HIV: speeding towards the future, learning from the past
Identifieur interne : 006395 ( Main/Exploration ); précédent : 006394; suivant : 006396How the SARS vaccine effort can learn from HIV: speeding towards the future, learning from the past
Auteurs : Anne S. De Groot [États-Unis]Source :
- Vaccine [ 0264-410X ] ; 2003.
Descripteurs français
- KwdFr :
- MESH :
- génétique : Virus du SRAS.
- immunologie : Coronaviridae, Syndrome respiratoire aigu sévère, Vaccins antiviraux, Vaccins contre le SIDA, Virus du SRAS.
- virologie : Syndrome respiratoire aigu sévère.
- Pascal (Inist)
- Wicri :
- topic : Vaccin.
English descriptors
- KwdEn :
- AIDS, AIDS Vaccines (immunology), Coronaviridae (immunology), Human immunodeficiency virus, Humans, Immunoprophylaxis, Learning, Prevention, SARS Virus (genetics), SARS Virus (immunology), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (prevention & control), Severe Acute Respiratory Syndrome (virology), Severe acute respiratory syndrome, Vaccine, Viral Vaccines (immunology).
- MESH :
- chemical , immunology : AIDS Vaccines, Viral Vaccines.
- genetics : SARS Virus.
- immunology : Coronaviridae, SARS Virus, Severe Acute Respiratory Syndrome.
- prevention & control : Severe Acute Respiratory Syndrome.
- virology : Severe Acute Respiratory Syndrome.
- Humans.
Abstract
A remarkable collaborative effort coordinated by the severe acute respiratory syndrome (SARS) team at WHO resulted in discovery of the etiologic agent of severe acute respiratory syndrome less than 2 months after the announcement of global alert. The development of a vaccine to prevent SARS should be pursued with the same urgency and cooperative spirit, as SARS is highly lethal and, if not controlled during the first few generations of transmission, is likely to become endemic in regions of the world where health-care infrastructure is underdeveloped and epidemiological control measures are weak. The scientific community already learned many important lessons from HIV vaccine development; these should be heeded. For example, consideration should be given to the development of a vaccine that will protect across regional strains of SARS, as the newly emergent coronavirus SARS-coronavirus (SARS-CoV) is proving to be variable and may be mutating in response to immune pressure. SARS-specific research reagents should also be collected and shared. These would include SARS peptides, adjuvants, DNA vaccine vectors and clinical grade viral vectors. Rapidly developing a collaborative approach to developing a SARS vaccine that will be both effective and safe is the only way to go. This article reviews parallels between HIV and SARS and proposes an approach that would accelerate the development of a SARS vaccine.
Url:
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000837
- to stream PascalFrancis, to step Curation: 000153
- to stream PascalFrancis, to step Checkpoint: 000958
- to stream Main, to step Merge: 006907
- to stream Pmc, to step Corpus: 000A07
- to stream Pmc, to step Curation: 000A07
- to stream Pmc, to step Checkpoint: 001892
- to stream PubMed, to step Corpus: 003179
- to stream PubMed, to step Curation: 003179
- to stream PubMed, to step Checkpoint: 003224
- to stream Ncbi, to step Merge: 000347
- to stream Ncbi, to step Curation: 000347
- to stream Ncbi, to step Checkpoint: 000347
- to stream Main, to step Merge: 006472
- to stream Main, to step Curation: 006395
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">How the SARS vaccine effort can learn from HIV: speeding towards the future, learning from the past</title><author><name sortKey="De Groot, Anne S" sort="De Groot, Anne S" uniqKey="De Groot A" first="Anne S." last="De Groot">Anne S. De Groot</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>TB/HIV Research Laboratory, Brown University</s1><s2>Providence, RI 02912</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Rhode Island</region><settlement type="city">Providence (Rhode Island)</settlement></placeName><orgName type="university">Université Brown</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">04-0414028</idno><date when="2003">2003</date><idno type="stanalyst">PASCAL 04-0414028 INIST</idno><idno type="RBID">Pascal:04-0414028</idno><idno type="wicri:Area/PascalFrancis/Corpus">000837</idno><idno type="wicri:Area/PascalFrancis/Curation">000153</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000958</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000958</idno><idno type="wicri:doubleKey">0264-410X:2003:De Groot A:how:the:sars</idno><idno type="wicri:Area/Main/Merge">006907</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126672</idno><idno type="RBID">PMC:7126672</idno><idno type="wicri:Area/Pmc/Corpus">000A07</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000A07</idno><idno type="wicri:Area/Pmc/Curation">000A07</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000A07</idno><idno type="wicri:Area/Pmc/Checkpoint">001892</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001892</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:14505885</idno><idno type="wicri:Area/PubMed/Corpus">003179</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003179</idno><idno type="wicri:Area/PubMed/Curation">003179</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003179</idno><idno type="wicri:Area/PubMed/Checkpoint">003224</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003224</idno><idno type="wicri:Area/Ncbi/Merge">000347</idno><idno type="wicri:Area/Ncbi/Curation">000347</idno><idno type="wicri:Area/Ncbi/Checkpoint">000347</idno><idno type="wicri:doubleKey">0264-410X:2003:De Groot A:how:the:sars</idno><idno type="wicri:Area/Main/Merge">006472</idno><idno type="wicri:Area/Main/Curation">006395</idno><idno type="wicri:Area/Main/Exploration">006395</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">How the SARS vaccine effort can learn from HIV: speeding towards the future, learning from the past</title><author><name sortKey="De Groot, Anne S" sort="De Groot, Anne S" uniqKey="De Groot A" first="Anne S." last="De Groot">Anne S. De Groot</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>TB/HIV Research Laboratory, Brown University</s1><s2>Providence, RI 02912</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Rhode Island</region><settlement type="city">Providence (Rhode Island)</settlement></placeName><orgName type="university">Université Brown</orgName></affiliation></author></analytic><series><title level="j" type="main">Vaccine</title><title level="j" type="abbreviated">Vaccine</title><idno type="ISSN">0264-410X</idno><imprint><date when="2003">2003</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Vaccine</title><title level="j" type="abbreviated">Vaccine</title><idno type="ISSN">0264-410X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term><term>AIDS Vaccines (immunology)</term><term>Coronaviridae (immunology)</term><term>Human immunodeficiency virus</term><term>Humans</term><term>Immunoprophylaxis</term><term>Learning</term><term>Prevention</term><term>SARS Virus (genetics)</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Severe acute respiratory syndrome</term><term>Vaccine</term><term>Viral Vaccines (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Coronaviridae (immunologie)</term><term>Humains</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Vaccins antiviraux (immunologie)</term><term>Vaccins contre le SIDA (immunologie)</term><term>Virus du SRAS (génétique)</term><term>Virus du SRAS (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>AIDS Vaccines</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Coronaviridae</term><term>Syndrome respiratoire aigu sévère</term><term>Vaccins antiviraux</term><term>Vaccins contre le SIDA</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronaviridae</term><term>SARS Virus</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Humains</term><term>Syndrome respiratoire aigu sévère</term><term>Virus immunodéficience humaine</term><term>Vaccin</term><term>Prévention</term><term>Immunoprophylaxie</term><term>Apprentissage</term><term>Syndrome respiratoire aigu sévère</term><term>SIDA</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Vaccin</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A remarkable collaborative effort coordinated by the severe acute respiratory syndrome (SARS) team at WHO resulted in discovery of the etiologic agent of severe acute respiratory syndrome less than 2 months after the announcement of global alert. The development of a vaccine to prevent SARS should be pursued with the same urgency and cooperative spirit, as SARS is highly lethal and, if not controlled during the first few generations of transmission, is likely to become endemic in regions of the world where health-care infrastructure is underdeveloped and epidemiological control measures are weak. The scientific community already learned many important lessons from HIV vaccine development; these should be heeded. For example, consideration should be given to the development of a vaccine that will protect across regional strains of SARS, as the newly emergent coronavirus SARS-coronavirus (SARS-CoV) is proving to be variable and may be mutating in response to immune pressure. SARS-specific research reagents should also be collected and shared. These would include SARS peptides, adjuvants, DNA vaccine vectors and clinical grade viral vectors. Rapidly developing a collaborative approach to developing a SARS vaccine that will be both effective and safe is the only way to go. This article reviews parallels between HIV and SARS and proposes an approach that would accelerate the development of a SARS vaccine.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Rhode Island</li></region><settlement><li>Providence (Rhode Island)</li></settlement><orgName><li>Université Brown</li></orgName></list><tree><country name="États-Unis"><region name="Rhode Island"><name sortKey="De Groot, Anne S" sort="De Groot, Anne S" uniqKey="De Groot A" first="Anne S." last="De Groot">Anne S. De Groot</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006395 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006395 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:04-0414028
|texte= How the SARS vaccine effort can learn from HIV: speeding towards the future, learning from the past
}}
| This area was generated with Dilib version V0.6.33. |  |